• Sign Up
  • |
  • Sign In Sign Out
  • |
  • Make us your home
  • |
  • RSS
1 2
1 15
1 5004
1 4
1 9
1 13
1 25
IPO
1 5013
  • Deccan Aviation gets DGCA permission to fly abroad
  • Idea, BSNL agree to interconnect RCom's GSM service
  • Flight cancelled due to workers strike
  • Cancel 11 flights to & from Kolkata on 20 Aug
  • To launch Mumbai services on Wednesday
  • Deccan Aviation gets permission to fly to UK
  • RBI relief bonds can be used as collateral for bk loan
  • July Producer Price Index at 27-year high; up 1.2%
  • U.S. Housing Starts down 11% in July, lowest in 17 years
  • Board okays buy back at price not exceeding Rs.350/share
  • Cannot say if interest rates have peaked: NW
  • RBI steps, inflation to determine interest rates : NW
  • BSE Power up 0.26% , Bankex up 0.10%
  • BSE Teck down 1.38% , Consumer Durables down 1.17%
  • CNX MidCap down 0.29% , BSE Small Cap down 0.34%
  • Sensex down 0.70% at 14,543.73
  • Nifty down 0.56% at 4,368.25
  • Expectations of U.K having 2 qtrs of -ve GDP growth
  • See further concerns emerging in U.S economy
  • Govt could be lender of last resort to Fannie and Freddie
  • EMs have seen $20bn fund outflows in last 10 weeks
  • Deccan Aviation granted traffic rights on India-UK sector
  • Revenues seen flowing in from Q4'09: Sources
  • Initial order size at $20-$25mn: Sources
  • Contracts to be signed within 3 months: Sources
  • Astrazeneca, Merck visited Dishman's facilities: Sources
  • Dishman to get orders from Merck & Astrazeneca: Srcs
  • India may import 3-3.5 MT of diesel this year : Oil Secy
  • To raise tractor prices this month : Escorts
  • Aluminium, Copper prices to remain weak in H2 FY'09
Updated: 19/08/08 | 06:24 PM IST
Pharma
Pharma major Lupin Ltd on Tuesday said it has entered into a multi-year promotion and marketing management for AeroChamber Plus line of products with Forest Lab Inc.
Comments: Read (0 ) Post
Pharmaceutical major Lupin Laboratories has entered into a promotion and marketing agreement with US-based Forest Laboratories for its Aerochamber line of products, it announced on Tuesday.
Comments: Read (0 ) Post
Indian drug makers are queuing up in Japan trying to get a first mover's advantage in a market, which is set to open its doors especially for generic pharmaceutical companies as they plan to flood the land of the rising sun with cheaper versions of blockbuster drugs.
Comments: Read (0 ) Post
India has sought the intervention of the US government in the case of Ranbaxy Laboratories, which is fighting the charges of fraudulent misconduct, levelled by the Department of Justice (DoJ), in district court of Maryland.
Comments: Read (0 ) Post
Zydus Cadila has entered into an agreement with WHO to explore a possible collaboration in the development of a cocktail for the treatment of rabies.
Comments: Read (0 ) Post
Government on Wednesday announced the approval of Japan-based Daiichi Sankyo's proposed acquisition of shares in domestic pharma major Ranbaxy.
Comments: Read (0 ) Post
Domestic pharma major Dr Reddy's Labs has said that a promoter group firm Dr Reddy's Laboratories Holdings Pvt Ltd has increased its stake in the company to 22.82 per cent through open market purchase.
Comments: Read (0 ) Post
Ranbaxy Laboratories on Tuesday said that the open offer by the Japanese drug maker Daiichi Sankyo for acquiring an additional 20 per cent stake in it will commence on August 16.
Comments: Read (0 ) Post
Japanese drug maker Daiichi Sankyo on Monday received approvals from the market regulator SEBI and Foreign Investment Promotion Board for the acquisition of 34.8 per cent stake in the Indian drug major Ranbaxy.
Comments: Read (0 ) Post
Orchid Chemicals and Pharmaceuticals on Monday said it has received European Union regulatory approval for marketing Piperacillin and Tazobactam injection, used in the treatment of bacterial infection.
Comments: Read (0 ) Post
Pages:
Special
Wholesale prices in the US rising at fastest pace since 1981
The US Labor Department said its Producer Price Index rose by 1.2 per cent in July, pushed higher by rising costs for energy and motor vehicles. Food prices rose by 0.3 per cent.

 
Market Watch
Graphs
Stocks
 
Trading Calls
Ashu Kakkar
Ashu Kakkar
2.01% status
Current: Rs 678.35
Hemen Kapadia
Hemen Kapadia
-0.59% status
Current: Rs 735.4
Stock Recos
I advice the investors to hold the stock
I would advice the investors to hold the stock